Cronos Extraction
Toronto, ON, CanadaFounded 2012
About Cronos Extraction
Cronos Group's extraction division focuses on innovative cannabinoid research and processing, backed by Altria's strategic investment, with emphasis on biosynthetic cannabinoid production.
Key Facts
- 1Altria Group invested CAD $2.4 billion for a 45% stake, funding extraction technology R&D
- 2Partnered with Ginkgo Bioworks to develop fermentation-based production of rare cannabinoids
Frequently Asked Questions
What is biosynthetic cannabinoid production?
Instead of extracting cannabinoids from plants, biosynthesis uses engineered yeast or bacteria to produce cannabinoids through fermentation, potentially at lower cost and higher purity.
Why did Altria invest in Cronos?
Altria, the tobacco giant behind Marlboro, invested in Cronos to gain exposure to the cannabis industry as a potential growth category amid declining cigarette sales.
More Cannabis Companies in Toronto
CRON Stock
View live price, chart & analysis
Products
- Cannabis Extracts
- Biosynthetic Cannabinoids
- Derivative Products
Specialties
Biosynthetic cannabinoid productionInnovative extraction R&D
Company Details
- Type
- Extraction
- Location
- Toronto, ON, Canada
- Founded
- 2012
- Publicly Traded
- Yes
- Ticker
- NASDAQ:CRON
Browse all Extraction
View more companies in this category
Related Companies
More in Canada
Tilray Brands
Leamington \u2014 Producer & Grower
Canopy Growth
Smiths Falls \u2014 Producer & Grower
Aurora Cannabis
Edmonton \u2014 Producer & Grower
Cronos Group
Toronto \u2014 Producer & Grower